PCV105 COST-EFFECTIVENESS OF GENEOTYPE-GUIDED DOSING OF SHORTTERM USE OF WARFARIN AMONG DVT/PE PATIENTS
Abstract
Authors
AR Teschemaker W Lawrence
AR Teschemaker W Lawrence
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now